UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2013-05, Vol.31 (13), p.1631-1639

2013

Volltextzugriff (PDF)

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1585-1591

2009

Volltextzugriff (PDF)

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Journal of clinical oncology, 2008-02, Vol.26 (4), p.657-664

2008

Volltextzugriff (PDF)

Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial

Journal of clinical oncology, 2003-02, Vol.21 (4), p.679-689

2003

Volltextzugriff (PDF)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2240-2250

2017

Volltextzugriff (PDF)

Whole-genome sequencing of cholangiocarcinoma to reveal distinct profiles of patients with underlying cirrhosis or inflammatory disorders

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.340-340

2021

Volltextzugriff (PDF)

First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8002-8002

2020

Volltextzugriff (PDF)

Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4142-4142

2021

Volltextzugriff (PDF)

hENT1 gene expression as a predictor of response to gemcitabine and nab-paclitaxel in advanced pancreatic cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4011-4011

2021

Volltextzugriff (PDF)

Age, race, and survival of men with de novo distant metastatic prostate cancer (M1PC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5031-5031

2016

Volltextzugriff (PDF)

Brigatinib in pretreated patients with ALK-positive advanced NSCLC

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9045-9045

2019

Volltextzugriff (PDF)

Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4630-4630

2020

Volltextzugriff (PDF)

Efficacy and safety of lurbinectedin (PM1183) in small cell lung cancer (SCLC): Results from a phase 2 study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.8570-8570

2018

Volltextzugriff (PDF)

Effect of defective ERCC2 on cisplatin and ionizing radiation (IR) sensitivity in bladder cancer cells

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.333-333

2017

Volltextzugriff (PDF)

Variability of physician perspectives toward advance care planning for patients with incurable cancer and congestive heart failure

Journal of clinical oncology, 2015-10, Vol.33 (29_suppl), p.12-12

2015

Volltextzugriff (PDF)

Intention to treat analysis of neoadjuvant chemoradiation and liver transplantation for perihilar cholangiocarcinoma

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.394-394

2016

Volltextzugriff (PDF)

Response to systemic therapy in non-clear cell renal cell carcinomas: A systematic review and meta-analysis

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.425-425

2014

Volltextzugriff (PDF)

Prospective evaluation of quality of life (QOL) during a phase I/II study of adjuvant chemotherapy with image-guided high-precision radiotherapy for completely resected gastric cancer

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.164-164

2016

Volltextzugriff (PDF)

Association between elevated blood pressure and clinical response in patients treated with anti-vascular endothelial growth factor (anti-VEGF) therapy in phase I clinical trials

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13506-e13506

2012

Volltextzugriff (PDF)

Prospective evaluation of perceived barriers to medication adherence by patients on oral antineoplastics

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6042-6042

2012

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Whole-genome sequencing of cholangiocarcinoma to reveal distinct profiles of patients with underlying cirrhosis or inflammatory disorders

First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study

Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC)

hENT1 gene expression as a predictor of response to gemcitabine and nab-paclitaxel in advanced pancreatic cancer

Age, race, and survival of men with de novo distant metastatic prostate cancer (M1PC)

Brigatinib in pretreated patients with ALK-positive advanced NSCLC

Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score

Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk patients (pts) with advanced renal cell carcinoma (aRCC) from CheckMate 214

Efficacy and safety of lurbinectedin (PM1183) in small cell lung cancer (SCLC): Results from a phase 2 study

Effect of defective ERCC2 on cisplatin and ionizing radiation (IR) sensitivity in bladder cancer cells

Variability of physician perspectives toward advance care planning for patients with incurable cancer and congestive heart failure

Intention to treat analysis of neoadjuvant chemoradiation and liver transplantation for perihilar cholangiocarcinoma

Response to systemic therapy in non-clear cell renal cell carcinomas: A systematic review and meta-analysis

Prospective evaluation of quality of life (QOL) during a phase I/II study of adjuvant chemotherapy with image-guided high-precision radiotherapy for completely resected gastric cancer

Association between elevated blood pressure and clinical response in patients treated with anti-vascular endothelial growth factor (anti-VEGF) therapy in phase I clinical trials

Prospective evaluation of perceived barriers to medication adherence by patients on oral antineoplastics

Aktive Filter

Suchergebnisse filtern